Results 221 to 230 of about 32,727 (251)

Update on Iron Chelators in Thalassemia

Hematology, 2010
AbstractOver the past four decades, there have been dramatic improvements in survival for patients with thalassemia major due in large measure to improved iron chelators. Two chelators are approved for use in the United States and Canada, parenteral deferoxamine and oral deferasirox.
openaire   +2 more sources

Clinical Challenges with Iron Chelation in Beta Thalassemia

Hematology/Oncology Clinics of North America, 2023
Janet L Kwiatkowski
exaly  

Iron chelators in medicine

Molecular Aspects of Medicine, 1992
openaire   +2 more sources

A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia

Annals of Medicine, 2022
Sherif M Badawy, Margaret Locke
exaly  

Effect of iron chelation on anti-pseudomonal activity of doxycycline

International Journal of Antimicrobial Agents, 2021
Marie-Eve Faure, Vincenzo Abbate, Agostino Cilibrizzi   +2 more
exaly  

Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation

Cell Stem Cell, 2019
Arnold Kriegstein, Robin Franklin, David Rowitch   +2 more
exaly  

Influence of iron chelation on the antioxidant activity of flavonoids

Biochemical Pharmacology, 1998
Dirk-Jan van den Berg, Aalt Bast, Wim J F van der Vijgh   +2 more
exaly  

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

Blood, 2009
Vinod Pullarkat
exaly  

Iron-Chelating Therapy for Transfusional Iron Overload

New England Journal of Medicine, 2011
TACCONE GALLUCCI, MASSIMO, MANCA DI VILLAHERMOSA, SIMONE, Noce, A.   +2 more
openaire   +5 more sources

Optimizing iron chelation strategies in β-thalassaemia major

Blood Reviews, 2009

exaly